Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123326444 | 12332644 | 4 | F | 201506 | 20160725 | 20160504 | 20160815 | PER | US-PFIZER INC-2016228237 | PFIZER | 61.00 | YR | F | Y | 56.70000 | KG | 20160815 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123326444 | 12332644 | 1 | PS | DETROL LA | TOLTERODINE TARTRATE | 1 | Oral | 2 MG, DAILY | N | C140365 | 21228 | 2 | MG | MODIFIED-RELEASE CAPSULE, SOFT | |||||
| 123326444 | 12332644 | 2 | SS | DETROL LA | TOLTERODINE TARTRATE | 1 | 4 MG, UNK | N | C150312 | 21228 | 4 | MG | MODIFIED-RELEASE CAPSULE, SOFT | ||||||
| 123326444 | 12332644 | 3 | SS | DETROL LA | TOLTERODINE TARTRATE | 1 | ONE 2MG PILL AND ONE 4MG PILL TO GET THE 6MG DOSE | N | 21228 | 6 | MG | MODIFIED-RELEASE CAPSULE, SOFT | |||||||
| 123326444 | 12332644 | 4 | SS | DETROL LA | TOLTERODINE TARTRATE | 1 | 2 MG, UNK | N | C148365 | 21228 | 2 | MG | MODIFIED-RELEASE CAPSULE, SOFT | ||||||
| 123326444 | 12332644 | 5 | SS | DETROL LA | TOLTERODINE TARTRATE | 1 | 2 MG, UNK | N | C140365 | 21228 | 2 | MG | MODIFIED-RELEASE CAPSULE, SOFT | ||||||
| 123326444 | 12332644 | 6 | SS | DETROL | TOLTERODINE TARTRATE | 1 | 4 MG, UNK | N | C158312 | 20771 | 4 | MG | |||||||
| 123326444 | 12332644 | 7 | SS | TOVIAZ | FESOTERODINE FUMARATE | 1 | 8 MG, UNK | N26746 | 22030 | 8 | MG | ||||||||
| 123326444 | 12332644 | 8 | C | MULTIVITAMIN FOR WOMEN | 2 | 1 PILL CUT IN HALF, HALF IN MORNING AND HALF IN EVENING | 0 | .5 | DF | BID | |||||||||
| 123326444 | 12332644 | 9 | C | CALCIUM | CALCIUM | 1 | Oral | 2 TABLETS BY MOUTH A DAY | 0 | 2 | DF | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123326444 | 12332644 | 1 | Hypertonic bladder |
| 123326444 | 12332644 | 6 | Hypertonic bladder |
| 123326444 | 12332644 | 7 | Hypertonic bladder |
| 123326444 | 12332644 | 8 | Vitamin supplementation |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123326444 | 12332644 | Drug ineffective | |
| 123326444 | 12332644 | Intentional product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123326444 | 12332644 | 1 | 201506 | 0 | ||
| 123326444 | 12332644 | 4 | 201506 | 201603 | 0 | |
| 123326444 | 12332644 | 6 | 201603 | 201605 | 0 | |
| 123326444 | 12332644 | 7 | 201605 | 0 | ||
| 123326444 | 12332644 | 8 | 201007 | 0 | ||
| 123326444 | 12332644 | 9 | 2009 | 0 |